Publications, Pharmaceutical

Why it is time to think differently about Nasal delivery of Biologics

COVID-19 has reinvigorated interest in the advantages of nasal delivery for a pharmaceutical industry already embracing a shift towards biologics.

This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.

Download Publication
Author(s): Gemma Budd Irene Rossi
4 Apr 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

22 Dec 2021

The Go-To Drug Delivery Expert

Brochures, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Product Solutions

Read More
22 Dec 2021

End-To-End Support at Every Stage of Your Drug Development Journey

Brochures, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation

Read More
13 Dec 2021

Towards A New Standard of Care with Aptar Pharma’s Digital Health

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations

Read More
8 Dec 2021

Aptar Pharma discusses an antibody nasal spray for SARS-CoV-2

Publications, Pharmaceutical, Innovation & Insights, Product Solutions

Read More
1 … 13 14 15 16 17 … 25

How Can We Help?

Back To Top